Opportunities to develop cutting edge medical practices are fast disappearing in the United States. When it comes to developing a new, improved way to treat patients, he can do it “quicker, develop it better, and have the ingredients to really take it much further” than he could in the same amount of time in the US Here, he can combine his clinical practice with scientific research and technological development, all at a breakneck pace. Clinical research and translational research is down 70% in the US

First, he blames “the lobbies, restrictions, confidentiality problems, insurance companies regulating what needs to be done, what can be done, what cannot be done…the usual ambulance chasing that occurs.” In the US there’s too much red tape.

Second, there’s an “inhibition of intellect coming together.” Because “provisions for funding are few and far between,” there is a huge amount of “talent divided among 200 universities” that don’t always collaborate.

us medical research too risk averse. and that does not even factor in the bible thumpers yet

• Uncategorized